Understanding basal cell adenocarcinoma of the head and neck: Population‐based study
Background Using a population‐based database, this study investigates the risk factors, epidemiology, and outcomes of basal cell adenocarcinoma (BCAC) of the head and neck. Methods The Surveillance, Epidemiology, and End Results database was analyzed for all patients with BCAC of the head and neck f...
Gespeichert in:
| Veröffentlicht in: | Head & neck 2022-02, Vol.44 (2), p.483-493 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 493 |
|---|---|
| container_issue | 2 |
| container_start_page | 483 |
| container_title | Head & neck |
| container_volume | 44 |
| creator | Ahsanuddin, Salma Jin, Ryan Sheorey, Lena Sawhney, Rohan Sangal, Neel R. Baredes, Soly Park, Richard Chan Woo |
| description | Background
Using a population‐based database, this study investigates the risk factors, epidemiology, and outcomes of basal cell adenocarcinoma (BCAC) of the head and neck.
Methods
The Surveillance, Epidemiology, and End Results database was analyzed for all patients with BCAC of the head and neck from 1973 to 2015.
Results
Three hundred and twenty‐two cases of BCAC of the head and neck were identified. Mean age of diagnosis was 64.1 years. 52.5% were male and 77.3% were white. The most common primary site was the parotid gland (71.7%). Most patients underwent surgery alone (51.9%). Five‐year disease‐specific survival (5Y‐DSS) was 95.6%, and 10Y‐DSS was 90.3%. Highest survival was seen with surgery alone followed by combined surgery and radiation (10Y‐DSS: 93.9% vs. 88.9%, p = 0.001). Age, primary site, T‐classification, grade, and treatment type significantly affected survival.
Conclusions
BCAC of the head and neck presents most frequently in the parotid glands. Surgery alone is associated with highest survival. |
| doi_str_mv | 10.1002/hed.26955 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2620012229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2620012229</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3535-e6f1c53902da70026763823020d525c70dcc54aa3d5883588f592c79fb635ba53</originalsourceid><addsrcrecordid>eNp1kLFOwzAQhi0EolAYeAFkiYkh7cWOk5oNlUKRKsFAWS3HdmhKGhc7EerGI_CMPAkuaUcG66zTd__pPoQuYhjEAGS4MHpAUs7YATqJgWcR0CQ73P4TGlHIkh469X4JADRNyDHq0YSzEYv5CXqd19o438hal_UbzqWXFVamqrDUprZKOlXWdiWxLXCzMHhhpMYBxrVR7zf42a7bSjalrX--vsOw0dg3rd6coaNCVt6c72ofze8nL-NpNHt6eBzfziJFGWWRSYtYMcqBaJmFS9IspSNCgYBmhKkMtFIskZJqNhrR8ArGicp4kaeU5ZLRPrrqctfOfrTGN2JpW1eHlYKkBCAmhPBAXXeUctZ7ZwqxduVKuo2IQWwNimBQ_BkM7OUusc1Xobsn98oCMOyAz7Iym_-TxHRy10X-Agw6ecI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2620012229</pqid></control><display><type>article</type><title>Understanding basal cell adenocarcinoma of the head and neck: Population‐based study</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Ahsanuddin, Salma ; Jin, Ryan ; Sheorey, Lena ; Sawhney, Rohan ; Sangal, Neel R. ; Baredes, Soly ; Park, Richard Chan Woo</creator><creatorcontrib>Ahsanuddin, Salma ; Jin, Ryan ; Sheorey, Lena ; Sawhney, Rohan ; Sangal, Neel R. ; Baredes, Soly ; Park, Richard Chan Woo</creatorcontrib><description>Background
Using a population‐based database, this study investigates the risk factors, epidemiology, and outcomes of basal cell adenocarcinoma (BCAC) of the head and neck.
Methods
The Surveillance, Epidemiology, and End Results database was analyzed for all patients with BCAC of the head and neck from 1973 to 2015.
Results
Three hundred and twenty‐two cases of BCAC of the head and neck were identified. Mean age of diagnosis was 64.1 years. 52.5% were male and 77.3% were white. The most common primary site was the parotid gland (71.7%). Most patients underwent surgery alone (51.9%). Five‐year disease‐specific survival (5Y‐DSS) was 95.6%, and 10Y‐DSS was 90.3%. Highest survival was seen with surgery alone followed by combined surgery and radiation (10Y‐DSS: 93.9% vs. 88.9%, p = 0.001). Age, primary site, T‐classification, grade, and treatment type significantly affected survival.
Conclusions
BCAC of the head and neck presents most frequently in the parotid glands. Surgery alone is associated with highest survival.</description><identifier>ISSN: 1043-3074</identifier><identifier>EISSN: 1097-0347</identifier><identifier>DOI: 10.1002/hed.26955</identifier><identifier>PMID: 34958519</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Adenocarcinoma ; Adenocarcinoma - diagnosis ; Adenocarcinoma - epidemiology ; Adenocarcinoma - therapy ; basal ; Cancer ; Epidemiology ; Head and neck ; Head and Neck Neoplasms - epidemiology ; Head and Neck Neoplasms - therapy ; Humans ; Male ; Middle Aged ; nationwide ; Neck - pathology ; otolaryngology ; Parotid gland ; Parotid Gland - pathology ; Patients ; Population studies ; Population-based studies ; Retrospective Studies ; Risk factors ; Salivary Gland Neoplasms - pathology ; Surgery</subject><ispartof>Head & neck, 2022-02, Vol.44 (2), p.483-493</ispartof><rights>2021 Wiley Periodicals LLC</rights><rights>2021 Wiley Periodicals LLC.</rights><rights>2022 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3535-e6f1c53902da70026763823020d525c70dcc54aa3d5883588f592c79fb635ba53</citedby><cites>FETCH-LOGICAL-c3535-e6f1c53902da70026763823020d525c70dcc54aa3d5883588f592c79fb635ba53</cites><orcidid>0000-0002-9081-2832</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhed.26955$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhed.26955$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34958519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahsanuddin, Salma</creatorcontrib><creatorcontrib>Jin, Ryan</creatorcontrib><creatorcontrib>Sheorey, Lena</creatorcontrib><creatorcontrib>Sawhney, Rohan</creatorcontrib><creatorcontrib>Sangal, Neel R.</creatorcontrib><creatorcontrib>Baredes, Soly</creatorcontrib><creatorcontrib>Park, Richard Chan Woo</creatorcontrib><title>Understanding basal cell adenocarcinoma of the head and neck: Population‐based study</title><title>Head & neck</title><addtitle>Head Neck</addtitle><description>Background
Using a population‐based database, this study investigates the risk factors, epidemiology, and outcomes of basal cell adenocarcinoma (BCAC) of the head and neck.
Methods
The Surveillance, Epidemiology, and End Results database was analyzed for all patients with BCAC of the head and neck from 1973 to 2015.
Results
Three hundred and twenty‐two cases of BCAC of the head and neck were identified. Mean age of diagnosis was 64.1 years. 52.5% were male and 77.3% were white. The most common primary site was the parotid gland (71.7%). Most patients underwent surgery alone (51.9%). Five‐year disease‐specific survival (5Y‐DSS) was 95.6%, and 10Y‐DSS was 90.3%. Highest survival was seen with surgery alone followed by combined surgery and radiation (10Y‐DSS: 93.9% vs. 88.9%, p = 0.001). Age, primary site, T‐classification, grade, and treatment type significantly affected survival.
Conclusions
BCAC of the head and neck presents most frequently in the parotid glands. Surgery alone is associated with highest survival.</description><subject>Adenocarcinoma</subject><subject>Adenocarcinoma - diagnosis</subject><subject>Adenocarcinoma - epidemiology</subject><subject>Adenocarcinoma - therapy</subject><subject>basal</subject><subject>Cancer</subject><subject>Epidemiology</subject><subject>Head and neck</subject><subject>Head and Neck Neoplasms - epidemiology</subject><subject>Head and Neck Neoplasms - therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>nationwide</subject><subject>Neck - pathology</subject><subject>otolaryngology</subject><subject>Parotid gland</subject><subject>Parotid Gland - pathology</subject><subject>Patients</subject><subject>Population studies</subject><subject>Population-based studies</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Salivary Gland Neoplasms - pathology</subject><subject>Surgery</subject><issn>1043-3074</issn><issn>1097-0347</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kLFOwzAQhi0EolAYeAFkiYkh7cWOk5oNlUKRKsFAWS3HdmhKGhc7EerGI_CMPAkuaUcG66zTd__pPoQuYhjEAGS4MHpAUs7YATqJgWcR0CQ73P4TGlHIkh469X4JADRNyDHq0YSzEYv5CXqd19o438hal_UbzqWXFVamqrDUprZKOlXWdiWxLXCzMHhhpMYBxrVR7zf42a7bSjalrX--vsOw0dg3rd6coaNCVt6c72ofze8nL-NpNHt6eBzfziJFGWWRSYtYMcqBaJmFS9IspSNCgYBmhKkMtFIskZJqNhrR8ArGicp4kaeU5ZLRPrrqctfOfrTGN2JpW1eHlYKkBCAmhPBAXXeUctZ7ZwqxduVKuo2IQWwNimBQ_BkM7OUusc1Xobsn98oCMOyAz7Iym_-TxHRy10X-Agw6ecI</recordid><startdate>202202</startdate><enddate>202202</enddate><creator>Ahsanuddin, Salma</creator><creator>Jin, Ryan</creator><creator>Sheorey, Lena</creator><creator>Sawhney, Rohan</creator><creator>Sangal, Neel R.</creator><creator>Baredes, Soly</creator><creator>Park, Richard Chan Woo</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><orcidid>https://orcid.org/0000-0002-9081-2832</orcidid></search><sort><creationdate>202202</creationdate><title>Understanding basal cell adenocarcinoma of the head and neck: Population‐based study</title><author>Ahsanuddin, Salma ; Jin, Ryan ; Sheorey, Lena ; Sawhney, Rohan ; Sangal, Neel R. ; Baredes, Soly ; Park, Richard Chan Woo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3535-e6f1c53902da70026763823020d525c70dcc54aa3d5883588f592c79fb635ba53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adenocarcinoma</topic><topic>Adenocarcinoma - diagnosis</topic><topic>Adenocarcinoma - epidemiology</topic><topic>Adenocarcinoma - therapy</topic><topic>basal</topic><topic>Cancer</topic><topic>Epidemiology</topic><topic>Head and neck</topic><topic>Head and Neck Neoplasms - epidemiology</topic><topic>Head and Neck Neoplasms - therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>nationwide</topic><topic>Neck - pathology</topic><topic>otolaryngology</topic><topic>Parotid gland</topic><topic>Parotid Gland - pathology</topic><topic>Patients</topic><topic>Population studies</topic><topic>Population-based studies</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Salivary Gland Neoplasms - pathology</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahsanuddin, Salma</creatorcontrib><creatorcontrib>Jin, Ryan</creatorcontrib><creatorcontrib>Sheorey, Lena</creatorcontrib><creatorcontrib>Sawhney, Rohan</creatorcontrib><creatorcontrib>Sangal, Neel R.</creatorcontrib><creatorcontrib>Baredes, Soly</creatorcontrib><creatorcontrib>Park, Richard Chan Woo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Head & neck</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahsanuddin, Salma</au><au>Jin, Ryan</au><au>Sheorey, Lena</au><au>Sawhney, Rohan</au><au>Sangal, Neel R.</au><au>Baredes, Soly</au><au>Park, Richard Chan Woo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Understanding basal cell adenocarcinoma of the head and neck: Population‐based study</atitle><jtitle>Head & neck</jtitle><addtitle>Head Neck</addtitle><date>2022-02</date><risdate>2022</risdate><volume>44</volume><issue>2</issue><spage>483</spage><epage>493</epage><pages>483-493</pages><issn>1043-3074</issn><eissn>1097-0347</eissn><abstract>Background
Using a population‐based database, this study investigates the risk factors, epidemiology, and outcomes of basal cell adenocarcinoma (BCAC) of the head and neck.
Methods
The Surveillance, Epidemiology, and End Results database was analyzed for all patients with BCAC of the head and neck from 1973 to 2015.
Results
Three hundred and twenty‐two cases of BCAC of the head and neck were identified. Mean age of diagnosis was 64.1 years. 52.5% were male and 77.3% were white. The most common primary site was the parotid gland (71.7%). Most patients underwent surgery alone (51.9%). Five‐year disease‐specific survival (5Y‐DSS) was 95.6%, and 10Y‐DSS was 90.3%. Highest survival was seen with surgery alone followed by combined surgery and radiation (10Y‐DSS: 93.9% vs. 88.9%, p = 0.001). Age, primary site, T‐classification, grade, and treatment type significantly affected survival.
Conclusions
BCAC of the head and neck presents most frequently in the parotid glands. Surgery alone is associated with highest survival.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>34958519</pmid><doi>10.1002/hed.26955</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-9081-2832</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1043-3074 |
| ispartof | Head & neck, 2022-02, Vol.44 (2), p.483-493 |
| issn | 1043-3074 1097-0347 |
| language | eng |
| recordid | cdi_proquest_journals_2620012229 |
| source | MEDLINE; Wiley Journals |
| subjects | Adenocarcinoma Adenocarcinoma - diagnosis Adenocarcinoma - epidemiology Adenocarcinoma - therapy basal Cancer Epidemiology Head and neck Head and Neck Neoplasms - epidemiology Head and Neck Neoplasms - therapy Humans Male Middle Aged nationwide Neck - pathology otolaryngology Parotid gland Parotid Gland - pathology Patients Population studies Population-based studies Retrospective Studies Risk factors Salivary Gland Neoplasms - pathology Surgery |
| title | Understanding basal cell adenocarcinoma of the head and neck: Population‐based study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A15%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Understanding%20basal%20cell%20adenocarcinoma%20of%20the%20head%20and%20neck:%20Population%E2%80%90based%20study&rft.jtitle=Head%20&%20neck&rft.au=Ahsanuddin,%20Salma&rft.date=2022-02&rft.volume=44&rft.issue=2&rft.spage=483&rft.epage=493&rft.pages=483-493&rft.issn=1043-3074&rft.eissn=1097-0347&rft_id=info:doi/10.1002/hed.26955&rft_dat=%3Cproquest_cross%3E2620012229%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2620012229&rft_id=info:pmid/34958519&rfr_iscdi=true |